(800) 258-1026

Find Out If Your CTCL Diagnosis Qualifies for Compensation

• Company
  This field is for validation purposes and should be left unchanged.
• Did you use Dupixent?*
  Select OneYesNo
• Are you willing to share medical records as proof?*
  Select OneYesNo
• Diagnosis or first biopsy 3–12 months after using Dupixent?*
  Select OneYesNo

• Do you have a history of any of the following conditions?*
  Select OneEpstein–Barr Virus (EBV)MononucleosisMonoHIV or AIDSPrior chemotherapy treatmentOrgan transplantImmune-suppressing meds used >6 months before first Dupixent doseReceived a COVID-19 vaccine within 30 days before CTCL diagnosisNo history of any of these conditions
• Were you diagnosed with cutaneous T-cell lymphoma (CTCL) after starting Dupixent?*
  Select OneMycosis fungoidesSézary syndromeOther
• Has CTCL been confirmed by a skin biopsy and pathology report?*
  Select OneYesNo biopsy confirmationSelf-suspected only

• Are you currently working with an attorney?*
  Select OneYesNo
• Name*
• Phone*
• What's your email address?*
• By clicking the “Next” and “SEE IF I QUALIFY” button below, I expressly consent to receive autodialed and/or prerecorded marketing phone calls and text messages at any time day or night from The Sentinel Group Law, or third-parties acting on its behalf, at the phone number provided above, including through the use of artificial intelligence. I acknowledge that I am not required to consent as a condition of purchasing or using any services. Msg. and data rates may apply.Terms of Use apply.

• Whoa! It looks like there is a '1' or a '0' at the start of your phone number. Please use format 9515551212 Thank you!

This Wasn’t What You Expected From Treatment

Dupixent was prescribed to help manage chronic conditions, not to raise concerns about a serious underlying disease.

If your symptoms worsened, changed, or led to a diagnosis of cutaneous T-cell lymphoma after starting Dupixent, you’re not alone in asking questions.

Patients rely on medications and medical guidance to improve their health. When outcomes take an unexpected turn, it’s reasonable to seek answers.
Here’s What Many Patients Experience

⚠️ Worsening or persistent skin symptoms
Rashes, plaques, or lesions that don’t respond to treatment and continue to spread or intensify after starting Dupixent

🧬 Delayed diagnosis through biopsy
What was initially treated as eczema or dermatitis later requires a skin biopsy, confirming CTCL, such as Mycosis Fungoides or Sézary syndrome

🩺 Ongoing medical treatment and monitoring
Patients may require dermatology visits, oncology care, repeated biopsies, and long-term disease management

💔 Emotional and physical toll
Living with a cancer diagnosis can bring anxiety, stress, fatigue, and disruption to daily life, relationships, and long-term plans

You May Have Legal Options

If you used Dupixent and were later diagnosed with cutaneous T-cell lymphoma confirmed by biopsy, you may be eligible to pursue a claim.

This includes cases where:

Skin symptoms worsened after starting treatment

A biopsy later confirmed CTCL

The diagnosis occurred months after Dupixent use

Seeking information about your legal options is a step toward understanding what happened and whether accountability may be pursued.

ATTORNEY ADVERTISEMENT

This website or its third-party tools use cookies, which are necessary for its functioning and required to achieve the purposes illustrated in the cookie policy, including the personalization and analysis of ads and content. If you want to learn more please refer to the cookie policy and privacy policy. You accept the use of cookies by scrolling this page, by clicking a link or button or by continuing to browse otherwise.